Showing results (2121-2130 of 3,888) with videos related to
Sort By:
Pageof 389
Cancer Biology & Therapy|April 4, 2006
Mutational hotspot in exon 20 of PIK3CA in breast cancer among Singapore ChineseXiaohui Liang, Quek Choon Lau, Manuel Salto-Tellez, et al.Cancer Biology & Therapy|April 1, 2006
ETS-TMPRSS2 fusion gene products in prostate cancerChristoph M Ahlers, William D FiggCancer Biology & Therapy|April 1, 2006
TKI-31 inhibits angiogenesis by combined suppression signaling pathway of VEGFR2 and PDGFRbetaLi Zhong, Xiao-Ning Guo, Xiu-Hua Zhang, et al.Cancer Biology & Therapy|April 1, 2006
Elegance, silence and nonsense in the mutations literature for solid tumorsScott E Kern, Jordan M WinterCancer Biology & Therapy|April 1, 2006
Enhancement of DNA vaccine potency by sandwiching antigen-coding gene between secondary lymphoid tissue chemokine (SLC) and IgG Fc fragment genesRongzhi Liu, Chunxia Zhou, Dongmei Wang, et al.Cancer Biology & Therapy|April 1, 2006
Preclinical studies of bismuth-213 labeled plasminogen activator inhibitor type 2 (PAI2) in a prostate cancer nude mouse xenograft modelSyed M Abbas Rizvi, Yong Li, Emma Yan Jun Song, et al.Cancer Biology & Therapy|July 25, 2006
Targeting XBP-1 as a novel anti-cancer strategyAlbert C Koong, Vibha Chauhan, Lorenzo Romero-RamirezCancer Biology & Therapy|August 2, 2006
Pheophorbide a, an active compound isolated from Scutellaria barbata, possesses photodynamic activities by inducing apoptosis in human hepatocellular carcinomaPatrick Ming-Kuen Tang, Judy Yuet-Wa Chan, Shannon Wing-Ngor Au, et al.Cancer Biology & Therapy|August 22, 2006
What are caspases 3 and 7 doing upstream of the mitochondria?Kageaki Kuribayashi, Patrick A Mayes, Wafik S El-DeiryCancer Biology & Therapy|March 23, 2006
DNA damage response: determining the fate of phosphorylated histone H2AXJonathan Rios-Doria, Alyson Fay, Aneliya Velkova, et al.Pageof 389